Jeff E. Knight Crinetics Pharmaceuticals, Inc. (CRNX) insider trading activity
Jeff E. Knight is Chief Operating Officer of Crinetics Pharmaceuticals, Inc.. Currently has a direct ownership of 52,580 shares of CRNX, which is worth approximately $2.36 Million. The most recent transaction as insider was on Jun 26, 2024, when has been sold 956 shares (Common Stock) at a price of $44.38 per share, resulting in proceeds of $42,427. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
52.6K
0%
3M change
52.85%
12M change
Total Value Held
$2.36 Million
Jeff E. Knight Transaction History
JEK
Jeff E. Knight
Chief Operating Officer
San Diego, CA